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Abstract
In skeletal muscle, the release of calcium (Ca
2+) by ryanodine sensitive sarcoplasmic reticulum (SR) Ca
2+ release channels
(i.e., ryanodine receptors; RyR1s) is the primary determinant of contractile filament activation. Much attention has been
focused on calsequestrin (CASQ1) and its role in SR Ca
2+ buffering as well as its potential for modulating RyR1, the L-type
Ca
2+ channel (dihydropyridine receptor, DHPR) and other sarcolemmal channels through sensing luminal [Ca
2+]. The genetic
ablation of CASQ1 expression results in significant alterations in SR Ca
2+ content and SR Ca
2+ release especially during
prolonged activation. While these findings predict a significant loss-of-function phenotype in vivo, little information on
functional status of CASQ1 null mice is available. We examined fast muscle in vivo and in vitro and identified significant
deficits in functional performance that indicate an inability to sustain contractile activation. In single CASQ1 null skeletal
myofibers we demonstrate a decrease in voltage dependent RyR Ca
2+ release with single action potentials and a collapse of
the Ca
2+ release with repetitive trains. Under voltage clamp, SR Ca
2+ release flux and total SR Ca
2+ release are significantly
reduced in CASQ1 null myofibers. The decrease in peak Ca
2+ release flux appears to be solely due to elimination of the
slowly decaying component of SR Ca
2+ release, whereas the rapidly decaying component of SR Ca
2+ release is not altered in
either amplitude or time course in CASQ1 null fibers. Finally, intra-SR [Ca
2+] during ligand and voltage activation of RyR1
revealed a significant decrease in the SR[Ca
2+]free in intact CASQ1 null fibers and a increase in the release and uptake kinetics
consistent with a depletion of intra-SR Ca
2+ buffering capacity. Taken together we have revealed that the genetic ablation of
CASQ1 expression results in significant functional deficits consistent with a decrease in the slowly decaying component of
SR Ca
2+ release.
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Introduction
Specialized systems have evolved for the robust and rapid
release of calcium (Ca
2+) ions from the sarcoplasmic reticulum
(SR) in skeletal and cardiac muscle. During skeletal muscle
activation, a single action potential initiates a release of ,200 mM
of Ca
2+ (per liter of fiber volume) from the SR which causes a
‘‘twitch’’ contraction. As the SR [Ca
2+] in fast muscle is at
approximately 30–40% of maximal capacity at rest, several groups
have estimated twitch release to be between 10–18% of the total
releasable SR Ca
2+ in fast twitch muscle from frog or mouse
[1,2,3,4]. However, repetitive trains of action potentials are a
hallmark of skeletal muscle activation. These contractions are
sustained by the reserve of releasable Ca
2+ in the basal state and a
rapid restoration of SR Ca
2+ content due to increased sarco-
endoplasmic reticulum ATPase activity (SERCA) and dynamic
refilling of the SR through sarcolemmal Ca
2+ influx (i.e.,
excitation-coupled calcium entry; ECCE [5,6,7]) during repetitive
stimuli. Recent work to elucidate the control of this dynamic
regulation of SR Ca
2+ has focused on calsequestrin (CASQ) and its
binding partners in the SR membrane as potential modulators of
the RyR1, the DHPR and other sarcolemmal channels through
sensing luminal [Ca
2+] [8,9,10].
Calsequestrins are acidic, high capacity Ca
2+ binding proteins in
the SR. Two isoforms of mammalian calsequestrin [11,12] have
been identified and characterized: a skeletal muscle and a cardiac
muscle isoform, or CASQ1 and CASQ2 respectively. CASQ2 is
the only isoform expressed in the heart. Whereas both CASQ1
and 2 are expressed in various skeletal muscles, fast muscle only
contains CASQ1 while slow muscle contains both isoforms
[13,14]. CASQ1 facilitates the accumulation of Ca
2+ within the
SR. The molecular basis for the tremendous binding capacity of
CASQ1 is in its behavior of forming polymer aggregates at high
[Ca
2+]. While the CASQ1 polymer networks facilitate an
accumulation of Ca
2+ close to the RyR, it is also clear that the
CASQ1 polymer arrangement facilitates the rapid off-loading of
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2+ during RyR channel opening [3]. During relaxation,
CASQ1 functions as a buffer of Ca
2+ in the SR lumen keeping
the free concentration relatively low and thus allowing more
efficient inward transport by the SERCA pumps [15,16,17,18].
This is particularly important in fast-twitch fibers where the
amount of Ca
2+ released and taken up is much greater than in
slow fibers [19]. The higher concentration of CASQ1 in fast fibers
[20,21] reflects its presumed important role in increasing the Ca
2+
content within the SR during repetitive contraction [22].
Genetic ablation of CASQ expression has proved to be an
important tool in elucidating the role of CASQ in cardiac and
skeletal muscles. Initial findings support the conclusion that CASQ
is NOT essential for EC coupling as ablation of CASQ1
expression in C. elegans [23], or ablation of CASQ1 [24] and both
CASQ1 and 2 [25] expression in mice were not lethal. In fact null
animals thrived and reproduced normally. Subsequent studies in
CASQ1 null mice [26] demonstrated little functional alteration of
isolated fast skeletal muscle and only a mild reduction in global
Ca
2+ signaling with single twitch stimulation. Since this report, a
detailed examination with prolonged depolarization in CASQ1
null myofibers revealed reduced peak and total SR Ca
2+ release
flux [27]. Most recently examination of both cytosolic transients
and intra-SR depletion kinetics with prolonged depolarization in
the CASQ1 null and CASQ1/2 double null mice, revealed a
decrease in the ability to sustain SR release flux [28] in null fibers.
However despite uncovering significant deficits at the level of the
SR in CASQ1 null mice these individual studies have provided
few functional correlates as a result of these deficits.
In this investigation we examined functional measures of muscle
performance in vivo and in vitro, measures of voltage dependent SR
Ca
2+ release and SR Ca
2+ release flux, as well as measures of SR
[Ca
2+] and its depletion during stimulation. We demonstrate that
genetic ablation of CASQ1 expression results in significant deficits
in functional performance in vivo. Furthermore, while in vitro
analysis of muscle contractility revealed minimal alterations in
maximal contractile activation, dramatic alterations in the ability
to sustain contractile function were seen with prolonged trains of
physiologic stimuli. Consistent with a steady reduction in the
amount of Ca
2+ available to allow contractile filament activation,
we identified a collapse of SR Ca
2+ release in Indo1 loaded
CASQ1 null myofibers as well as a decrease in SR Ca
2+ release
flux and total SR Ca
2+ release in voltage clamped CASQ1 null
myofibers. Finally, CASQ1 null myofibers had a significant
reduction in total releasable SR [Ca
2+] and altered kinetics of
release and uptake consistent with the lack of a significant SR Ca
2+
buffer. Taken together we have demonstrated that the genetic
ablation of CASQ1 expression results in significant deficits in SR
Ca
2+ storage and release which in-turn contribute to significant
deficits in contractile activation and whole animal functional
performance.
Results
CASQ1 null mice exhibit decrements in gross
neuromuscular performance
Voluntary exercise capacity has recently been used as a sensitive
measure of deficits caused by the deletion of putative EC coupling
proteins [29]. Here we provided exercise naı ¨ve CASQ1 null (n=6)
and WT (n=6) mice free access to computerized running wheels
for 14 days. The mean 24 hour running distance from the final
three days was taken as the voluntary exercise capacity. CASQ1
null animals exhibited a significant deficit in total daily running
distance compared to the WT group (Fig. 1A). Likewise, treadmill
exercise capacity (i.e., forced exercise; Fig. 1B) was significantly
reduced in CASQ1 nulls compared to age matched WT mice.
Forepaw gripstrength,asensitiveassayused todetectdysfunction
in several murine models of motor neuron [30,31,32] and muscle
Figure 1. Neuromuscular phenotyping in vivo.A .Voluntary
exercise capacity: Mice (CASQ1 null; n=6) and WT; n=6) were singly
housed in a cage with a mouse running wheel (Lafayette Instruments,
Lafayette, IN) in a 12/12 hour light/dark animal facility with ad libitum
access to food and water. The number of wheel revolutions were
computer analyzed per 24 hour period and data was converted to
mean number of meters per day and reported as descriptive data.
When compared to the WT group (8.6460.99 km), the CASQ1 null
animals (4.7561.41 km) exhibited a significant deficit in total daily
running distance (t-test, p,0.05) B. Treadmill exercise capacity (i.e.,
non-voluntary) was evaluated in previously sedentary CASQ1 null (n=6)
and WT (n=6). Following an a 3 day acclimation period (see methods),
mice were exercised at 10 meters/minute for the first 10 min then
ramped to 20 m/min over 1 min and held there until volitional
exhaustion. Volitional exhaustion was assessed by a single rater,
blinded to mouse genotype, who determined the time point at which
the mouse was unable to maintain treadmill pace after two successive
startles. After the trial, total time was converted to distance covered.
Exercise naı ¨ve WT mice performed significantly better (490680 m;
n=6) than age matched CASQ1 null mice (2806130 km; n=6). C.
Forepaw grip strength was determined on a commercial rodent grip
strength meter (Columbus Inst., USA) as described (see methods).
CASQ1 null mice (n=8) exhibited a significant deficit in grip strength (C;
left panel) compared to WT (n=8) mice when normalized to
bodyweight (3.6860.17 vs. 4.2460.14 g?bdwt
21; t-test, p,0.05). The
body weight of the WT mice was approximately 18% larger than those
of the CASQ1 null animals (34.5860.26 g vs. 28.1461.36; t-test,
p,0.05). The decrement in force between the peak value and the
value of the 7
th trial was evaluated as an index of fatigue (C; right panel)
and expressed as % of initial.CASQ1 null animals exhibited more fatigue
than did their WT counterparts.
doi:10.1371/journal.pone.0027036.g001
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cular performance. The peak force in each of 7 successive trials was
determined and the 2 highest values were averaged and normalized
to bodyweight. As seen in Fig. 1C (left), CASQ1 null mice (n=8)
exhibited a significant deficit in grip strength normalized to body
weight compared to WT mice (n=8). As seen previously [24], the
body weight of the WT mice was approximately 18% greater than
that of the CASQ1 null animals. The relative drop in the peak grip
strength over the 7 trials was assessed as the index of grip strength
fatigue. As seen in Fig. 1C (right), CASQ1 null animal exhibited
more fatigue over the 7 successive trials than did their WT
counterparts.
Assays of muscle contractility reveal significant deficits in
CASQ1 null mice
To evaluate the muscle specific contribution to the deficits seen
in the neuromuscular function assays, we examined muscle
contractility in vitro in explanted whole EDL muscles surgically
excised from age matched WT and CASQ1 null mice as we have
previously described [34,35]. Each muscle’s tendons were affixed
with ligatures between a fixed post and a tension transducer
(isometric mode) in a bath and the muscle superfused with
oxygenated physiologic saline. Isometric tension was evaluated
with trains of pulses delivered at 1, 30, 50, 80, 100,150 and
300 Hz. Figure 2A displays the peak isometric force vs. stimulation
frequency relationship between EDLs from WT (n=8) and
CASQ1 null (n=8) mice. While a large decrease in absolute peak
force output was apparent in CASQ1 null muscles, these results
were likely influenced by the significant differences in the muscle
wet weight as EDL muscles from the CASQ1 null mice were
approximately 29% smaller in mass than those from the WT age
matched controls. To allow direct comparison of specific force
generation between genotypes, the peak isometric tension
produced was normalized to muscle cross sectional area (CSA)
[36] (see methods).
Following CSA normalization there were small but significant
differences in the amplitudes of the force vs. stimulation frequency
relationship (Fig. 2B) at low frequency trains (1 and 20 Hz and
40 Hz) but there were no differences were seen at any other
frequency, indicating that the majority of the loss in absolute force
in un-normalized data was due to decreased muscle mass. Kinetic
analysis revealed a significant decrease in the time-to-peak of the
twitch in the CASQ1 null EDLs at the 1 Hz stimulus frequency
without any difference in the maximal rate of rise (+dP/dT).
However, examination of the maximal tetanic transient (300 Hz)
revealed that both time-to-peak and +dP/dT were faster during
tetanic contractions in CASQ1 null EDLs compared to WT
(Table 1).
Despite the similarity of the peak of normalized force
production by the WT and CASQ1 null EDL muscles, visual
inspection of the raw force records revealed dramatic differences
in the time course between the two genotypes. As seen in
representative raw records from the force vs. frequency experi-
ment, (1, 20, 40, 80, 300 Hz; Fig. 3A, top) CASQ1 null EDLs
were unable to sustain peak force during trains of action potentials,
and exhibited a significant reduction of tension during the train.
The temporal relationship of this decline is more evident when
these traces are normalized to the peak of the transient (Fig. 3A,
bottom). The inability of CASQ1 null muscles to maintain their
isometric force was even more evident when we increased the
duration of the pulse train from 300 to 1500 msec. Fig. 3B displays
a representative set of raw traces from a WT and CASQ1 null
muscles during 1500 msec train of 100 Hz pulses. In this
experiment, it is clear that the fade in isometric tension in the
Figure 2. EDL Force vs. stimulation frequency relationship
assayed in vitro. Trains of pulses (0.2 msec.) delivered at 1, 30, 50, 80,
100,150 and 300 Hz. A. The absolute isometric force vs. stimulation
frequency relationship between WT and CASQ1 null EDLs revealed
significantly reduced tension in the CASQ1 nulls between 40–300 Hz.
However, EDL muscles from the CASQ1 null mice (7.5860.43 mg; n=8)
were approximately 29% smaller in mass than those from the WT age
matched controls (10.7360.71 mg; n=8, t-test, p,0.05). B. Following
CSA normalization the force vs. stimulation frequency relationship
revealed small but significant differences in the amplitudes of low
frequency trains (1 and 20 Hz and 40 Hz) while no differences were
seen at any other frequency (ANOVA).
doi:10.1371/journal.pone.0027036.g002
Table 1. Kinetic parameters of EDL contractility in vitro.
WT CASQ1 null
EDL Weight
(mg)
10.7360.71‘ 7.5860.43‘
Twitch
(1 Hz)
Tetanic
(300 Hz)
Twitch
(1 Hz)
Tetanic
(300 Hz)
Force (g) 5.7260.45 36.6662.93
& 5.5860.96 19.1862.1
&
Max dp/dt
(msec)
3.7561.8 8.062.5
# 4.061.4 14.663.9
#
Time to
peak(s)
0.10160.012
* 0.09360.008
‘ 0.04560.018
* 0.06560.013
‘
Like symbols indicate significance p,0.05.
doi:10.1371/journal.pone.0027036.t001
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value by 800 msec while WT muscle showed little change in
tension over the 1500 msec (Fig. 3C).
Taken together, these results suggest that while the EDL muscle
from CASQ1 null animals has significant deficits in total force
output, when normalized to muscle cross sectional area force
output is only mildly altered (Fig. 2). Furthermore, while CASQ1
null muscle was able to activate the contractile apparatus in similar
fashion as the WT, the CASQ1 null EDLs had a dramatic fade in
the temporal evolution of the force transient during a 1500 msec
pulse train.
FDB myofibers from CASQ1 null mice exhibit significant
deficits in electrically evoked Ca
2+ transients
As Ca
2+ release from the sarcoplasmic reticulum (SR) is a
positive predictor of myofiber contractile force generation [37], we
next asked whether alterations in Ca
2+ release from the SR,
contributed to the significant ‘fade’ in force phenotype seen in
muscles from CASQ1 null mice.
Action potential-evoked Indo1 Ca
2+ transients are altered
in CASQ1 null muscle fibers
First, we sought to evaluate action-potential evoked Ca
2+
transients and Ca
2+ homeostasis in single, intact WT and CASQ1
null muscle fibers stimulated by single or repetitive field
stimulation. FDB fibers from 5–7 week old mice were loaded
with the ratiometric Ca
2+ indicator Indo1-AM and after dye
conversion stimulated with field electrodes as previously described
[38]. Fig. 4A illustrates average responses from 13 control and 21
CASQ1 null fibers stimulated by a single (1 ms; 14 V) field
stimulus followed by a train (240 ms) of 1 ms/14 V pulses at
100 Hz. There was a significant reduction in the cytosolic Ca
2+
Figure 3. Representative raw force records from WT and CASQ1 null mice. A Raw records (top) and same records normalized to peak
tension (A, bottom) from the EDL force vs. frequency experiment (WT=black, CASQ1 null=red) with 500 msec trains of pulses of 1, 20, 40, 80,
300 Hz. (see Fig. 2A for aggregated data of maximal tension). CASQ1 null EDL muscles exhibited a frequency dependent inability to sustain force
during the pulse train. Note that significant difference in maximal force generation normalized when the differences in muscle mass were accounted
for (see Fig. 2B.). B. Representative normalized force traces from a WT and CASQ1 null muscle in which a 1500 msec train of pulses was delivered at
100 Hz. C. In 4 EDL muscles from each genotype, we demonstrated that while WT muscle showed little change in tension over the 1500 msec,
developed tetanic tension in the CASQ1 null muscles fell to 85.266.7% (t-test, p,0.05) of the peak value.
doi:10.1371/journal.pone.0027036.g003
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right bar plot). This difference was even more striking during
repetitive stimulation where compared to WT counterparts there
was a rapid collapse of the Ca
2+ transient in the CASQ1 null fibers
(Fig. 4A). Consistent with single stimulation, the first indo1 Ca
2+
transient elicited during a train was reduced in CASQ1 null
(Fig. 4A; red trace) compared to WT fibers (Fig. 4A; black trace)
and then unlike WT fibers the CASQ1 null fibers were unable to
maintain the summation of calcium signal during repetitive
stimulation (Fig. 4A). Figure 4C shows the average WT and
CASQ1 null indo1 ratios normalized to the initial peak of the last
train. Both WT and CASQ1 null fibers showed an initial increase
in the peak amplitude during the first 100 ms of 100 Hz train.
However, while the subsequent transients during the train in WT
fibers continued to rise, in CASQ1 null fibers the relative
amplitude of the Ca
2+ transients during the train declined
significantly (Fig. 4C).
SR Ca
2+ release flux is suppressed in CASQ1 null
myofibers
Fig. 5 shows averaged time course of fluo-4 Ca
2+ transients
elicited by 80 ms step depolarization to a range of voltages and
expressed as F/F0 obtained from WT (Fig. 5A, N=4) and CASQ1
null fibers (Fig. 5B, N=4). The pulse protocol utilized both an
initial and final voltage pulse to 220 mV and a series of
intervening pulses to 260 mV to +20 mV at 20 mV step
increments, followed by another sequence of pulses ranging from
+10 to 250 mV, decreasing the amplitude in 20 mV increments,
with a reference pulse to 220 mV at the start, middle and end of
the sequence, as shown in Fig. 5. A correction for possible changes
in the fibers resting fluorescence over the course of each
experiment was applied by normalizing all records in the second
sequence by the ratio of the DF/F0 values, obtained by dividing
DF/F0 from the middle pulse from the first sequence to that in the
second sequence in order to arrive at the corrected F/F0 records
Figure 4. CASQ1 null muscle fibers exhibit a decreased peak amplitude of action potential-evoked indo-1 Ca
2+ transient. A. Average
indo-1 transient responses to a single AP stimuli followed by a 250 msec. 100 Hz train of APs from WT (black trace; n=13) and CASQ1 null (red trace;
n=21) fibers. Indo-1 responses show reduced amplitude of Ca
2+ transients after single and tetanic stimulation in CASQ1 null fibers. B. Bar plot
summarizing the peak indo 1 transient after correcting for indo-1 saturation. Significant differences in peak Indo-1 were found in CASQ1 null fibers
(WT=1.3360.04, CASQ1 null=0.8360.03, p,0.05,, p,0.05). C. Traces from A normalized to initial transient amplitude to demonstrate lack of
summation of the Ca
2+ transient during repetitive stimulation of CASQ1 null fibers when compared to WT counterpart (last/first ratio WT=1.9160.02,
n=13; CASQ1 null=0.8160.04, n=21; Mann-Whitney rank-sum test, p,0.05).
doi:10.1371/journal.pone.0027036.g004
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cytosolic Ca
2+ concentration (free [Ca
2+]) by using Eq. 3 (see
methods).
The estimation of the Ca
2+ release flux in each fiber was then
calculated from its free Ca
2+ waveform. For each fiber, the rate of
Ca
2+ release from the inside of the SR into the cytosol was
calculated using Eq. 5. Figs. 5C and 5E represent the average of
the records of cytosolic free [Ca
2+] and the Ca
2+ release flux from
4 WT fibers, while corresponding data on the right (Fig. 5D and
5F) are the averages from 4 CASQ1 null fibers. The absence of
CASQ1 greatly suppressed the average fluo-4 signal at each
voltage, as well as the calculated free Ca
2+, the magnitude of the
initial peak and the later more sustained component of Ca
2+
release for all pulses. Using data obtained from each of the fibers in
Fig. 5E and 5F, values of the peak release rates were calculated
and plotted as a function of voltage as illustrated in Fig. 6A. The
data were fitted to a single Boltzmann function described by the
following equation [38]:
RV ðÞ ~Rmax= 1zexp Vhalf{V

=k
 
ð6Þ
where Rmax is the maximum release rate, Vhalf defines the potential
when R=0.5 Rmax, and 1/k is a measure of the steepness of the R-
V relationship. Average Rmax, Vhalf and k parameters were
32.6 mMms
21, 233.4 mV and 15.2 mV and 73.6 mMms
21,
230.9 mV and 12.3 mV for CASQ1 null and WT fibers
respectively. This analysis reveals a 55% decrease (N=4) in the
maximum peak Ca
2+ release in the CASQ1 null fibers compared
to WT. Fig. 6B plots the R-V curves normalized to Rmax, allowing
a better visualization of effect of ablation of CASQ1 expression on
Figure 5. Fluo-4 fluorescence transients are altered in CASQ1 null FDB myofibers. Free [Ca
2+] and Ca
2+ release flux from WT (left) and
CASQ1 null fibers (right). Average (n=4) time course of fluo-4 F/F0 records expanded in time elicited at different voltages are displayed for WT fibers
(A) and for CASQ1 null fibers (B). (C) and (D) are free [Ca
2+] waveforms derived from A and B while (E) and (F) are Ca
2+ release flux calculated from C
and D. Comparison of the two sets of data show significant suppression of the amplitude of F/F0, free Ca
2+ and peak and maintained Ca
2+ release flux
in the CASQ1 null fibers.
doi:10.1371/journal.pone.0027036.g005
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2+ release. The Vhalf
values shown here indicate a non-significant shift of 3 mV in the
voltage-dependence of Ca
2+ release in CASQ1 null animals
(Fig. 6A and B).
Figures 7A–D present superimposed Ca
2+ release flux records in
WT and CASQ1 null fibers for 4 different voltages. The figures
show a very significant reduction in the peak values of the Ca
2+
release flux at voltages that elicited Ca
2+ release i.e., 240 mV,
220 mV, 0 mV, and +20 mV. The peak Ca
2+ release flux of the
CASQ1 null fibers were more strongly suppressed relative to WT
fibers at higher depolarizations. In addition, the total amount of
Ca
2+ released from the SR at each voltage, which corresponds to
the time integral or area of the release flux records (data not
shown) is markedly decreased in the CASQ1 null fibers, consistent
with a greatly reduced total SR Ca
2+ content.
In WT fibers, each of the Ca
2+ release waveforms for larger
depolarizations (e.g., 0, +20 mV) is characterized by a pronounced
early peak that occurs within 10 ms of the application of the
pulse(Fig. 7C–D; black traces). This is then followed by an initial
rapid decline and then a much slower decline, with a temporal
profile that is believed to reflect an early partial inactivation of
RyR1 followed by a time dependent decline of the SR Ca
2+
content and/or a partial decline in SR Ca
2+ permeability
[39,40,41]. In this interpretation, the early peak represents the
maximum amplitude of the sum of the amplitudes of the rapidly
decaying and the slowly decaying component of Ca
2+ release at
each voltage. The amplitude of the shoulder just after completion
of the rapid phase of decline in the release flux records from the
WT fibers represents the initial magnitude of the slowly decaying
phase of release flux. In considering the release records from this
perspective, it appears that the slowly decaying phase of decay of
release flux is almost totally abolished in the CASQ1 null fibers. In
contrast, the rapidly decaying component is hardly altered. In
order to compare the kinetic properties of the Ca
2+ release flux in
fibers from WT and CASQ1 null mice, Ca
2+ release flux time
courses for CASQ1 null and control (WT) fibers were plotted
together and normalized to the peak values at voltages that elicited
Ca
2+ release (i.e. 240 mV, 220 mV, 0 mV, and +20 mV;
Fig. 7E–H). The kinetics of the peak formation and time to peak
appear no different in WT and CASQ1 null fibers at all voltages
examined as illustrated by the time-expanded insets in Figures 7E–
H. However, the rate of decay of the total release records in
CASQ1 null fibers is similar in time course to the rate of decay of
the fast component in the WT fibers, so much so that the slow
component is virtually eliminated (Fig. 7A–H).
Figure 8 quantitatively compares the properties of the 2 phases
of decay of Ca
2+ release in WT and CASQ1 null fibers. The
amplitude and time constant of decay of the rapidly decaying
component were obtained from a single exponential fit to the
decay of the rapid component from the beginning of its decay to
20 ms after the start of the pulse for pulses to +20 mV. The
amplitude of the slow phase was taken as the constant in the same
single exponential plus constant fits. There was no significant
difference in the amplitude or decay time constant of the rapidly
decaying component of release. In contrast, the mean amplitude of
the slowly decaying component of release was significantly reduced
in the null fibers to 24% of the mean value for the control fibers
(p,0.05), further supporting the selective suppression of the slowly
decaying component of release in CASQ1 null fibers.
In order to further explore the slowly decaying component of
release in WT and CASQ1 null fibers, we terminated the pulse to
+20 mV after either 20 or 80 ms. As shown in Fig. 9, terminating
the pulse after 20 ms in WT fibers caused a clear decrease in the
fluorescence signal (Fig. 9, A) and in the corresponding calculated
Ca
2+ release flux record (Fig. 8, C), indicating that release was still
active when the pulse was terminated at 20 ms. Thus the slowly
decaying component of release was clearly present in WT fibers
since the rapidly decaying component was already terminated by
20 ms at+20 mV (Fig.7H,inset). In contrast, inCASQ1 null fibers,
terminating the pulse after 20 ms had essentially no effect on the
either the fluorescence signal (Fig. 9 B) or on the calculated Ca
2+
release flux (Fig. 9 D). Thus, Ca
2+ buffering from CASQ1 appears
to maintain SR Ca
2+ levels so as to allow a slowly decaying
component of release in WT fibers. In contrast, in CASQ1 null
fibers this buffering is lacking and release ceases after the end of the
rapidly decaying component. However, since neither the amplitude
nor the decay time constant of the rapidly decaying component of
release are altered in CASQ1 null fibers, one can conclude that
CASQ1 buffering of the intra luminal SR Ca
2+ plays no role in
determining the rapidly decaying component of release.
FDB myofibers from CASQ1 null mice have a decrease in
releasable SR Ca
2+ content
A challenge with 1 mM 4-Chloro-m-Cresol (4-CmC) was used
to assay maximal depletion of SR[Ca
2+]free in FDB myofibers SR
Figure 6. Peak Ca
2+ release flux vs. voltage relationship in WT and CASQ1 null myofibers. A. Peak Ca
2+ release flux was plotted as a
function of voltage in CASQ1 null and WT fibers. Data was fitted to a single Boltzmann function with the following parameters: Rmax, Vhalf and k
parameters were 32.6 mMms
21, 233.4 mV and 15.2 mV and 73.6 mMms
21, 230.9 mV and 12.3 mV for CASQ1 null and WT fibers respectively. B. Peak
release flux vs. voltage normalized to the Rmax allows for better estimation of the effect the absence of CASQ1 on voltage dependence and on the
steepness of Ca
2+ release. Non-significant differences in the voltage-dependence parameters of Ca
2+ release from CASQ1 nulls were found.
doi:10.1371/journal.pone.0027036.g006
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2+ indicator Fluo5N,by a technique
recently published by our group [42]. In both WT and CASQ1
null fibers, superfusion with 4-CmC initiated a rapid decrease to
sustained nadir in intra-SR Fluo5N fluorescence that recovered
with the removal of 4-CmC from the superfusate. This response is
consistent with the evacuation and re-sequestration of Ca
2+ by the
Figure 7. The kinetics of the Ca
2+ release time courses differ between CASQ1 null and WT myofibers. Superimposed average Ca
2+
release time courses at 240 mV (A), 220 mV (B), 0 mV (C) and +20 mV (D) voltage steps from WT (black traces) and CASQ1 null fibers (red traces).
(E–H) Time course of the normalized Ca
2+ release flux in the WT and CASQ1 null fibers derived from panels A–D to show effects of CASQ1 elimination
on the kinetics of Ca
2+ release. Insets show zoom-in versions of the raising phase of the rate of Ca
2+ release. The kinetics of the peak formation appear
unchanged from the WT fibers to the CASQ1 null fibers however the slow component is virtually eliminated, suggesting a rapid decline of the SR Ca
2+
content in the absence of CASQ1.
doi:10.1371/journal.pone.0027036.g007
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profiles (i.e., DF/F4-CmC) of a WT and a CASQ1 null myofiber.
The maximum sustained nadir in F4-CmC was taken as the
maximum depletion of SR Ca
2+
free as 1 mM 4-CmC releases
.98% of the releasable SR Ca
2+ content [42]. With the nadir of
the DF/F4-CmC normalized to maximum SR depletion (e.g., zero
SR Ca
2+ content), the change in fluorescence (DF=F initial -
Fdepetion) was normalized to Fdepetion to yield the DF/F4-CmC.I n
this presentation the DF/F4-CmC at the start of the experiment
minus the DF/F4-CmC at the nadir represents the relative
SR[Ca
2+] content. Here we report that when compared to WT,
CASQ1 null fibers exhibited a ,24% reduction SR [Ca
2+]
compared to WT myofibers (Fig. 10B).
Additional qualitative insight was gained by examining the
temporal evolution of the fluorescence during the 4-CmC
challenge. We found that WT myofibers exhibited latency prior
to the start of depletion compared to the CASQ1 null myofibers,
in which SR Ca
2+ content declined immediately. As these ex-
periments were performed with bath perfusion of 4-CmC, quan-
titative analysis was not possible. However, we speculate that the
absence of CASQ1 as a Ca
2+ buffer was responsible for the
immediate decline in fluorescence caused by agonist challenge in
contrast to the slower decline in the WT fibers.
A detailed evaluation of the temporal evolution of the SR[Ca
2+]
evacuation and recovery was assayed with prolonged 50 Hz trains
of AP’s using field stimulation. Recently we demonstrated that this
protocol could produce ,98% depletion of the SR[Ca
2+]free in WT
myofibers [42]. Fig. 9A displays a representative DF/F Fluo5N
fluorescence profile (i.e., F-Fstim/Fstim) normalized to the maximal
depletion to highlight the temporal kinetics. Following the initiation
of tetanicstimulation (0.5 ms pulse @ 50 Hz) in both genotypes, SR
Ca
2+ content reached the nadir relatively rapidly, and recovered
soon after the stimulation was terminated. On an expanded time
scale it was also evident that there was a delay prior to the final
exponential decay of SR Ca
2+ content in WT fibers that was not
present in the CASQ1 null fibers. As a result, the decay time to the
nadir was very much shorter in the CASQ1 null fibers (Fig. 11B).
The evacuation rate of the SR, estimated by fitting the rapid
fluorescence decline with a mono exponential decay, revealed a
significantly faster evacuation rate in CASQ1 null myofibers
compared to WT with the rate of depletion (Fig. 11C) of SR Ca
2+
content was significantly faster in the CASQ1 nulls. This
relationship can be better appreciated in the time expanded lower
inset of panel 11A. Here the slight delay for WT myofibers to reach
the maximal release rate is evident while the CASQ1 null myofibers
drop rapidly from the start of the depolarization. This result in the
CASQ1 nulls is consistent with the lack of an SR Ca
2+ buffer to
sustain SR [Ca2+]free during release.
Finally, the recovery kinetics following stimulation were
examined and taken as SERCA refilling the SR. This recovery
Figure 8. Kinetics of the rapidly decaying component of the release flux at 20 mV in WT and CASQ1 null fibers. A decaying
exponential fit to the Ca
2+ release flux at 20 mV was used to determine the amplitude and time constant of the rapidly decaying component of the
release flux in both WT and CASQ1 null fibers. The offset of the exponential fit corresponds to an estimate the amplitude of the slow decaying
component of the release. A and B independently show comparison of the amplitudes of the fast and of the slow decaying component in both WT
and CASQ1 null fibers respectively (n=7). B shows that the amplitude of the slowly decaying component of release in CASQ1 null fibers was
significantly reduced when compared to WT counterparts (* denotes p,0.05) while no significant changes occurred in the amplitude and the decay
time constant of the rapidly decaying component of release in CASQ1 null fibers.
doi:10.1371/journal.pone.0027036.g008
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WT fibers and a two component exponential function in the
CASQ1 nulls, a finding consistent with the recent report by
Canato et al [28]. A comparison of the time constant (Tau) for the
WT and the Tau for the initial rise (Tau1) of the CASQ1 null
revealed that CASQ1 null myofibers recovered more rapidly than
WT myofibers (Fig. 9D; Tau1=0.32360.034 vs. Tau=
0.48860.031 sec. respectively).
Discussion
Recent studies in muscle fibers with varied levels of CASQ1
[43] as well is in muscle fibers genetically depleted of CASQ1 and
or CASQ1 and 2 [24,27,28,44] have demonstrated that CASQ is
not required for EC coupling, but have reaffirmed its importance
as a Ca
2+ buffer in skeletal muscle SR. However, in light of the
importance of the identified changes in SR function in the absence
of CASQ1, given that only minor changes in the functional
contractility phenotype have been identified [24] despite severe
dysfunction and death when environmental heat stress is imposed
or after exposure to volatile anesthetics [44] there is an apparent
incongruence between the functional phenotypes in relation to SR
function.
In the present investigation we used assays of functional
performance in vivo as well as assays of contractility and SR
Ca
2+ handling in vitro to gain additional insight into the functional
Figure 9. CASQ1 null fibers lack the slowly decaying component of release. Fluo-4 fluorescence transient measured as DF/F0 for WT (left)
and CASQ1 null fibers (right). A is the time course of fluo-4 records averaged from 3 WT fibers and B is the time course obtained for CASQ1 null fibers
averaged from 3 fibers. 20 mV depolarizing pulses were applied and subsequently terminated at either 20 ms or 80 ms as illustrated on top of figures
A and B in order to evaluate the slowly decaying component of release in both WT and CASQ1 null fibers. C and D are Ca
2+ release flux calculated
from A and B. The results showed that CASQ1 buffering triggered a slowly decaying component of release in WT fibers while CASQ1 null fibers
lacking this buffering does not exhibit this slowly decaying component of release.
doi:10.1371/journal.pone.0027036.g009
Figure 10. CASQ1 null myofibers have a reduction in relative
SR [Ca
2+]free.A .Representative SR Fluo5N fluorescence profile of a WT
and CASQ1 null myofibers challenged with 1 mM 4-CmC. This profile
was normalized to the maximum 4-CmC depletion (DF/F4-CmC). B. The
evaluation of Finitial as a surrogate to SR [Ca
2+]free (see results) revealed
that CASQ1 null myofibers had a ,24% reduction in relative SR
[Ca
2+]free compared to WT myofibers (Mann-Whitney rank-sum test,
P,0.05).
doi:10.1371/journal.pone.0027036.g010
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are: (A.) Both voluntary and involuntary exercise capacity was
greatly reduced in the CASQ1 null mice. (B.) While a substantial
deficit in peak force produced by the CASQ1 null EDL muscles
could be almost fully accounted for by a decrease in mass these
muscles exhibited a dramatic frequency dependent inability to
sustain tension during a pulse train. (C.) With electric field
stimulation of intact FDB fibers there is a significant decrease in
the Ca
2+ transients in CASQ1 null myofibers for single action
potentials, and a collapse of the Ca
2+ transient with repetitive
trains of pulses. (D) Under voltage clamp, the peak SR Ca
2+
release flux, as well as total SR Ca
2+ release is significantly reduced
in CASQ1 null fibers. The suppression of Ca2+ release flux in
CASQ1 null fibers appears to be due to a selective suppression of
the slowly decaying component of SR Ca
2+ release (E.) There is a
significant decrease in the SR [Ca
2+]free and a increase in the SR
[Ca
2+] decay and reuptake kinetics in CASQ1 null muscles
consistent with a loss of an intra-SR Ca
2+ buffering capacity.
Taken together we have determined that the genetic ablation of
CASQ1 expression results in significant deficits in contractile
activation consistent with alterations in SR Ca
2+ release and/or
SR [Ca
2+].
The slowly decaying component of SR Ca
2+ release is
selectively eliminated in CASQ1 null fibers
An interesting novel result in the present report is the finding
that the decrease in peak Ca
2+ release flux in CASQ1 null fibers
appears to be solely due to elimination of the slowly decaying
component of SR Ca
2+ release, whereas neither the amplitude nor
the time course of the rapidly decaying component of SR Ca
2+
release is altered. One possible explanation for this finding could
be that the rapidly decaying component of release comes from an
intra-SR Ca
2+ pool that is not buffered by CASQ1, whereas the
slowly decaying component comes from another SR pool that is
buffered by CASQ1. Alternatively, the rapidly decaying compo-
nent of release could already be completed by an early time point
Figure 11. The dynamics of SR depletion and recovery are altered in CASQ1 null myofibers. A. Representative DF/F Fluo5N fluorescence
profiles (normalized to max depletion) during 50 Hz sustained train of pulses. Offset lower panel is a time expanded trace. B. The half time of decay
of the Fluo5N fluorescence signal during the 50 Hz train of stimulation was greatly reduced in the CASQ1 null fibers compared to the WT
(0.04660.004 sec. vs. 0.16460.027, t-test, p,0.05) C. The evacuation rate of the SR was estimated by fitting the rapid fluorescence decline with a
mono exponential function revealed a significantly faster evacuation rate (i.e., depletion tau), in CASQ1 null myofibers compared to WT
(tau=0.06460.005 vs. 0.2360.030 sec. respectively). D. The recovery of Fluo5N fluorescence following stimulation was best fit with a mono-
exponential function in the WT and a two component exponential function in the CASQ1 null. A comparison of repletion Tau for the WT and the Tau
of the initial exponential rise (Tau1) of the CASQ1 null revealed that CASQ1 null myofibers recovered more rapidly the WT myofibers
(Tau1=0.32360.034 vs. Tau=0.48860.031 sec. respectively, t-test, p,0.05).
doi:10.1371/journal.pone.0027036.g011
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2+] had
not yet significantly declined (e.g., earlier than 20 ms after the start
of a pulse to +20 mV; see Fig. 9). Independent of the underlying
mechanism, our findings support the general conclusion that
CASQ1 null myofibers exhibit a temporal collapse in the Ca
2+
transient due to a progressive failure to maintain the level of
SR[Ca
2+]free. The net result is that CASQ1 null myofibers show a
significant decrease in the magnitude of peak SR Ca
2+ release flux
(,55%) with no significant change in the voltage-dependence of
Ca
2+ release (Fig. 6A and B).
A recent paper has also focused on differences in Ca
2+ release in
voltage clamped WT or CASQ1 null FDB fibers using the same
CASQ1 mutant mouse strain and very similar voltage clamp and
Ca
2+ indicator methods as used here together with simultaneous
optical monitoring of SR luminal [Ca
2+] [41], which was not done
here. Based on their results using longer pulses than used here they
concluded that SR Ca
2+ release permeability (i.e., the ratio of SR
Ca
2+ release flux to SR[Ca
2+]) is appreciably decreased 400 to
500 msec after the start of large depolarizing pulses in WT fibers.
By contrast, our voltage clamp studies focused on events occurring
during the first 10 to 20 msec following the start of similar large
depolarizing steps. Independent of any possible later SR Ca
2+
permeability changes in the WT fibers, our results showed that
both amplitude and time course of the rapidly decaying com-
ponent of SR Ca
2+ release was essentially unchanged in CASQ1
null fibers, whereas the slowly decaying component of release was
fully eliminated. Our use of relatively brief (20 ms) depolarizing
pulses served as an empirical test of this interpretation. The late
occurring events (i.e., .400 msec) studied by Sztretye et al. [41]
by which SR Ca
2+ permeability changed in WT fibers but not in
CASQ1 null fibers, were not examined here. In contrast, by
focusing on the events early during depolarization we show that
the component of release that turns off within 10–20 ms of the
start of a large depolarization is independent of the presence or
absence of CASQ1, whereas the more slowly decaying component
of release appears to be totally dependent on the presence of
CASQ1.
A corollary to our conclusion that the slowly decaying
component of SR Ca
2+ release is eliminated in CASQ1 null
fibers, but the rapidly decaying component is unchanged is that
the total Ca
2+ release from the SR should be considerably smaller
in CASQ1 null than in WT fibers. Whether the 40% suppression
in measured total SR Ca
2+ released in EGTA buffered CASQ1
null fibers [41] corresponds to this prediction remains to be
determined.
CASQ1 null FDB myofibers have a decrease in the
releasable SR[Ca
2+]free
Based on recent reports with sustained or repetitive depolar-
izations, CASQ1 null myofibers are reported to have a reduction
in the releasable SR [Ca
2+]free of between 20% [27] and .65%
[28] when compared to WT. Here we report a ,24% decrease in
4-CmC releasable SR [Ca
2+]free in CASQ1 null myofibers. In
these experiments we used 5 mM BAPTA-AM to assist in the
suppressing of movement during 4-CmC induced Ca
2+ release (see
[42]). As BAPTA at this concentration is likely to reduce Ca
2+
dependent inactivation of the RyR1[41,42], we believe that
activation with 4-CmC (1 mM) represented maximal SR [Ca
2+]-
free depletion and is thus an accurate estimate of SR [Ca
2+]free.
In the 4-CmC experiments, we observed an apparent increase
in the rapid phase of SR depletion followed by an increase in the
rate of SR[Ca
2+] recovery. Quantification of these responses was
not attempted however as the temporal initiation and cessation of
the 4-CmC was in question with the bath superfusion. In
experiments with prolonged trains of 50 Hz tetani we were able
to precisely identify the temporal point of activation and ter-
mination and here we report a significant increase in the eva-
cuation rate of SR[Ca
2+]free as well as an increase in rate of Ca
2+
re-sequestration in the CASQ1 null fibers; results consistent with a
decrease in the amount of intra SR buffer due to the absence of
CASQ1. In WT muscle fibers, the CASQ1-Ca
2+ store acts to sus-
tain SR Ca
2+ content, and thereby Ca
2+ release. In the CASQ1
nulls this buffered store is absent, causing the Ca
2+
free to be more
rapidly depleted during activation. During re-sequestration, the
CASQ1 in the WT muscle acts to sequester SR Ca
2+ during re-
filling thus reducing the rate of the accumulation of SR[Ca
2+]free.
The decrease in in vivo and in vitro functional
performance in CASQ1 null animals is consistent with a
decrease in SR Ca
2+ release
Based on the severe deficits in SR Ca
2+ handling that have been
reported in CASQ1 null fibers during prolonged depolarization
under voltage clamp [27] as well as with more physiologically
relevant trains of brief depolarizations [27,28] we reasoned that
functional phenotypes that relied on similar prolonged fiber
activations would reveal concomitant loss-of-function phenotypes
in vivo and in vitro.
To address muscle specific functional performance we per-
formed contractility assays in vitro in EDL muscles. Consistent with
previous reports by Paolini et al (2009) we identified a significant
reduction of maximal twitch or tetanic force in the CASQ1 null
(Fig. 2A). Interestingly, this deficit could be almost completely
explained by the loss in muscle mass in the CASQ1 null animals
rather than by the lack of CASQ1 per se. However, despite the
similarity in force generation per unit muscle area, we demonstrate
for the first time that CASQ1 null EDL muscle showed a fre-
quency dependent collapse in the force transient (Fig. 3). These
data are most consistent with decreased SR Ca
2+ release/in-
creased evacuability and/or reduction in Ca
2+ store content that
we and others [24,27,28,41] have now shown in the CASQ1 null.
An additional functional correlate of the SR Ca
2+ handing
phenotype that we observed in the CASQ1 null were the signi-
ficant increases in the rate of rise and concomitant decrease in
time to peak in force transients, which is consistent with the
increased rate of intra-SR Ca
2+ evacuation and the decreased time
of Ca
2+ re-sequestration relaxation we identified in these muscles
(Table 1).
In the context of the in vitro functional phenotype we can
consider more readily the functional phenotypes identified in vivo.
Our assays identified a peripheral locomotor muscle specific
functional deficit in the CASQ1 null mice. First, grip strength was
markedly reduced and grip fatigue was increased in CASQ1 null
mice; two non-specific in vivo assays of peripheral neuromuscular
function. Second, we demonstrated that both voluntary and
involuntary exercise capacity was greatly reduced in the CASQ1
null mice. It is important to note that in neither instance did the
mice exhibit signs of distress or death during or following activity
which would have indicated severe metabolic complications such
as was demonstrated in these mice when challenged by
environmental heat stress [44]. Furthermore, because CASQ1 is
only expressed in the skeletal muscle and not in the heart, this loss-
of-function exercise phenotype is likely independent of cardiovas-
cular function deficits identified in the CASQ2 null mice [25].
Instead we believe functional performance was limited by intrinsic
deficits in skeletal muscle performance (i.e., peripheral locomotor
and/or respiratory) due to the lack of CASQ1.
It is clear that in vivo physiologic function was likely affected by a
complex array of deficits including the loss in muscle mass and
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2+ handling identified here. The decrease in
exercise capacity and increased fatigability is in apparent contrast
however to the report that EDL muscles from CASQ1 null mice
fatigue slower in vitro than WT [24]. The decrease in EDL fatigue
in CASQ1 null mice in vitro, which we have quantitatively
confirmed (data not shown), has been recently addressed by Zhao
et al. [8] who demonstrate that CASQ1 knockdown with siRNA
results in a significant increase in store operated Ca
2+ influx
(SOCE) in apparent compensation for the increased depletion of
the SR during muscle fiber activation. Based on our functional
assessments in vivo (i.e., treadmill, running wheel, grip) it is clear
that this enhancement in SOCE that decreases fatigue in vitro does
not fully compensate for the EC coupling dependent processes that
are needed to sustain physiologic function in vivo.
Methods
Animal Models
All experiments involving animals were conducted according
to the National Institutes of Health Guide for the Care and Use of
Laboratory Animals, and were approved by the Institutional Animal
Care and Use Committee of the University Of Maryland School
Of Medicine (Approval # 1210009). C57BL/6 CASQ1 null mice
[24] were raised at Charles River Laboratories, and shipped to
the animal facility at 4–8 wks of age. All experiments were
conducted on adult mice (3 month610 days). Aged matched
C57BL/6 mice, obtained from Charles River laboratories, were
used as controls.
Gross neuromuscular performance
Voluntary exercise capacity was assessed in previously sedentary
CASQ1 null (n=6) and wild type (WT; n=6). Mice were singly
housed in a cage with a mouse running wheel (Lafayette
Instruments, Lafayette, IN) in a 12/12-hour light/dark animal
facility with ad libitum access to food and water. The number of
wheel revolutions was computer analyzed per 24-hour period and
data was converted to mean number of meters per day and
reported as descriptive data.
Treadmill exercise capacity (i.e., non-voluntary) was evaluated in
previously sedentary CASQ1 null (n=6) and WT (n=6). The
protocol was similar that of Massett and Berk [45] except with
slight modifications. On day 1 the mice were acclimatized to the
treadmill compartment for 5 min without treadmill activity. On
days 2 and 3 mice were acclimated to the treadmill at a low speed
(0% grade; 10 & 12 m/min respectively). On Day 4 mice were
exercised at 10 meters/minute for the first 10 min then ramped to
20 m/min over 1 min and held there until volitional exhaustion.
Prior to fatigue mice were encouraged to maintain running pace
by non-noxious ‘‘startle’’; a tap on the hindquarter with an 11 inch
forceps. Volitional exhaustion was assessed by a single rater,
blinded to mouse genotype, who determined the time point at
which the mouse was unable to maintain treadmill pace after two
successive startles. After the trial, total time was converted to
distance covered. Differences in total distance by group were
analyzed by Student’s t-test.
Forepaw grip strength was determined on a commercial rodent
grip strength meter (Columbus Inst., USA). Peak grip strength
was assessed in 7 successive trials separated by 10–15 seconds by
a single rater blinded to genotype. The highest two values were
averaged, normalized to bodyweight and used as a measure of the
peak grip strength. The decrement in force between the peak
value and the value of the 7
th trial was evaluated as an index of
fatigue.
In vitro muscle contractility
Muscle performance of the extensor digitorum longus (EDL) was
assessed in vitro using methods described previously [34]. In brief,
single EDL muscles were surgically excised with ligatures at each
tendon (5-0 silk suture) and mounted in an in vitro bath between a
fixed post and force transducer (Aurora 300B-LR) operated in
isometric mode. The muscle was maintained in physiological
saline solution (PSS; pH 7.6) containing (in mM) 119 NaCl, 5
KCl, 1 MgSO4, 5 NaHCO3, 1.25 CaCl2,1K H 2PO4, 10, HEPES,
10 glucose, and maintained at 30uC under aeration with 95 O2/5
CO2 (%) throughout the experiment. During a 5 min equilibra-
tion, single twitches were elicited at every 30 seconds with supra-
maximal electrical pulses (200 msec.sec) via platinum electrodes
running parallel to the muscle. For brief tetanic stimuli 250 msec
trains of pulses were delivered at 1, 10, 20, 40, 60, 80, 100, 150 Hz
and isometric tension was evaluated. After the experimental
protocol, the muscle rested for 5 min at which time muscle length
was determined with a digital micrometer, and the muscle was
trimmed proximal to the suture connections, blotted and weighed.
The cross-sectional area for each muscle was determined by
dividing the mass of the muscle (g) by the product of its length (Lo,
mm) and the density of muscle (1.06 g/cm
3; [36]). Muscle
performance is expressed as isometric tension (g.mm
2) per cross-
sectional area. Statistical comparisons between groups were
performed using ANOVA procedures (SigmaStat v3.1). Signifi-
cance set at p,0.05.
FDB fiber preparation
Fibers were prepared using enzymatic dissociation of flexor
digitorum brevis (FDB) muscles of 6- to 7-week-old CASQ1 null
and WT mice, and were cultured as previously described [46].
Indo1 ratiometric recordings
Indo1 AM ratiometric recording and analysis were performed
as previously described [47] but with some modifications for
loading. Briefly Cultured FDB fibers were loaded with indo1-AM
(2 mM for 30 min at 22uC; Invitrogen, Eugene, OR) in L-15
media (ionic composition in mM: 137 NaCl, 5.7 KCl, 1.26 CaCl2,
1.8 MgCl2, pH 7.4; Invitrogen, Eugene, OR). Then the fibers
were washed thoroughly with appropriate L-15 media to remove
residual Indo1 AM and incubated at 22uC for another 30 min to
allow dye conversion. The culture dish was mounted on an
Olympus IX71 inverted microscope and viewed with an Olympus
606/1.20 NA water immersion objective. Fibers were illuminated
at 360 nm, and the fluorescence emitted at 405/30 and 485/
25 nm was detected simultaneously. The emission signals were
digitized and sampled at 2 KHz using a built-in AD/DA converter
of a EPC10 amplifier and the acquisition software Patchmaster
(HEKA, Instruments). Field stimulation (1 ms, 8–14 V and
alternating polarity) was provided by a custom pulse generator
through a pair of closely spaced (0.5 mm) platinum electrodes.
Electrophysiology
Membrane current measurements were performed using the
whole-cell configuration of the patch-clamp technique [48] with
modifications for mammalian FDB fibers detailed previously.
[38,49,50]. Whole cell Ca
2+ current measurements were carried
out using external solution containing the following (in mM): 150
TEA-CH3SO3, 2 CaCl2, 1 MgCl2, 10 Hepes, 0.001 TTX, 1 4-
aminopyridine, 0.025 N-benzyl-p-toluene sulfonamide (BTS), and
pH of solution adjusted to 7.4 with CsOH. The pipette solution
(internal) contained (in mM): 140 Cs-CH3SO3, 10 Hepes, 20
EGTA, 6 MgCl2, 11.5 CaCl2, 4 Na2ATP, 14 creatine phosphate,
Functional Performance Deficits in Casq1 Null Mice
PLoS ONE | www.plosone.org 13 December 2011 | Volume 6 | Issue 12 | e270360.3 Na2GTP, and 0.1 leupeptin and solution pH adjusted to 7.4
with CsOH to obtain a buffered solution.
Fluo-4 high-speed line-scan (x-t) confocal microscopy
Fluo-4 fluorescence line-scan (100 ms/line) confocal microscopy
measurements were carried out on a Zeiss LSM 5 Live system as
previously described [38] Fibers were dialyzed for 20 minutes via
the patch pipette with 50–75 mM fluo-4 5K
+. Typically, the
voltage depolarization steps were applied 300 ms after the start of
the confocal scan sequence, thus providing control images prior to
stimulation at the start of each sequence. These control images
were used to determine the resting steady-state fluorescence level
(F0). Average intensity of fluorescence as a function of time (F(x,t))
within selected areas of interest (AOIs) were measured using Image
Examiner (Carl Zeiss, Jena). The average F0 value in each AOI
prior to test pulse is used to scale fluo4 fluorescence in the same
AOI as F/F0.
Time course of free myoplasmic Ca
2+ concentration
In order to estimate the time course of free [Ca
2+] during a Ca
2+
transient in these fibers the fluorescence F/F0 signal must be
corrected for both dye saturation and for the kinetic delay in dye
equilibrium. The kinetic lag and dye saturation can be corrected
using an approach previously described for Fura-2 ratio signals
[51] but adapted here for F/F0 records [52]. Under conditions
when the dye is not at equilibrium with the cytosolic free Ca
2+, the
time course of cytosolic free Ca
2+concentration ([Ca]cyto(t)), is
given by:
Ca ½  cyto(t)~KDdf(1=koffd)dF(t)=dt
zF(t){F ming=fF max{F(t)g
ð1Þ
(see [51]), Eq. 5, with rearrangements), where KDd is the
dissociation constant for Ca
2+ from the indicator dye, koffd is
the off rate constant for Ca
2+ dissociation from the dye, F is the
fiber fluo-4 fluorescence signal and Fmax and Fmin are the
fluorescence at saturating and zero free Ca
2+, respectively.
When the concentration is changing slowly, the following
condition applies:
½Ca &KDdf(F{F min)=(F max{F)g : , ð2Þ
Then, average [Ca
2+]cyt (t) is derived from F(t)/F0 [52] as:
½Ca2z cyto(t)~½Ca2z cyto(0)f(F(t)=F0)
zf(1=koffd)(d(F(t)=F0=dt)g,
ð3Þ
where [Ca
2+]cyto(0) is free cytosolic [Ca
2+] at resting levels. This
equation assumes that the dye is far from saturation by Ca
2+,
which appears justified for fluo-4 considering that [Ca
2+]cyto was
always much lower than the value of fluo-4’s KD previously
determined using in situ calibrations [38]. [Ca
2+]cyto(0) was set to
0.081 mm. This assumption was roughly consistent with measure-
ments of resting [Ca
2+] under similar experimental conditions
using the ratiometric indicator indo-1 [53]. The indo-1 fluores-
cence emission ratio did not change significantly with time starting
20 min after whole-cell configuration establishment.
Calculation of Ca
2+ release flux
Under the conditions of 20 mM EGTA with added Ca
2+ in the
pipette, EGTA still the major binding site for released Ca
2+.I n
that case d [Ca-EGTA](t)/dt provides a good approximation to
the rate of SR Ca release in the fiber, and will be used in the Ca
2+
release calculations presented here. For Ca
2+ binding to EGTA,
d½Ca-EGTA (t)=dt~
kone½Ca (t)½EGTA (t)-koffe½Ca-EGTA (t),
ð4Þ
where kone and koffe are on and off rate constants for Ca
2+ binding
to EGTA.
½EGTA (t)~½EGTA tot{½CaEGTA (t),
d½CaEGTA (t)=dt~kone½Ca (t)f½EGTA tot
{½CaEGTA (t)g{koffe½CaEGTA (t),
ð5Þ
Equation 5 was solved numerically using [Ca
2+]cyto(t) from Eq. 3,
and using the Euler method to calculate the time course of d[Ca-
EGTA](t)/dt, which was used as the time course of the rate of
Ca
2+ release from the SR during the voltage clamp pulses.
[EGTA] and [Ca-EGTA] inside the fiber at the start of each pulse
were assumed to be 70% of that estimated for the pipette solution
(obtained with the programs Maxchelator [54]. and Bound and
determined [55]. The parameter values used in our calculations
were koffd=90 s-1 [52,56] and koffe=1.2 s-1 (EGTA
KD=0.08 mM).
Assay of free intra-SR [Ca
2+]
Methods for the Fluo5N loading of FDB’s and measures of 4-
CmC and electrical depletion were conducted as previously
described [42]. In brief, enzymatically isolated FDB’s were loaded
in a solution of fluo-5N (Invitrogen, Carlsbad, CA) dissolved in
20% pluronic in DMSO, and diluted in DMEM to a final
concentration of 10 mM. Loading was at 37uC for 2 hr, to allow
uptake of dye into the cytosol and its de-esterification in the lumen
of the SR. Following loading, cells were incubated for 1 hr at room
temperature followed by 1 hr at room temperature in medium
containing 5 mM 1,2-Bis(2-aminophenoxy)ethane-N,N,N9,N9-tet-
raacetic acid tetrakisacetoxymethyl ester (BAPTA-AM;Invitrogen,
Carlsbad, CA) dissolved in 20% pluronic in DMSO) and 25 mM
N-benzyl-p-toluene sulfonamide (BTS; Sigma Aldrich, St. Louis,
MO; dissolved in DMSO), to prevent contraction during imaging.
During 37uC loading of fluo-5N, fibers were plated on cover slips
coated with Matrigel (BD Biosciences, San Jose, CA). BAPTA-AM
also reduced the fluorescence arising from fluo-5N molecules
remaining in the cytosol and minimized the loss of fibers caused by
the maximal release of Ca
2+ from the SR. Fibers were studied
within 2 hr after loading was terminated.
Fibers loaded with fluo-5N were imaged in normal Tyrode’s
solution (NT), containing (in mM), 140 NaCl, 0.5 MgCl2, 0.3
NaH2PO4, 5 HEPES, 5.5 glucose, 1.8 CaCl2, and 5 KCl, pH
of7.4 with NaOH. Confocal images were acquired on an inverted
microscope (Axiovert 200 M LSM-510; Carl Zeiss, Germany)
equipped with an oil immersion objective (406, 1.2 NA) and a
488 nm excitation laser in line scan (xt) mode.
Changes in the fluo-5N signal in response to application of
1 mM 4-chloro-m-cresol (4-CmC) in the bath were recorded with
the confocal microscope in line scan mode. Fluo-5N was excited
with a 488 nm laser and emitted light was filtered through a long
pass, 505 nm filter.
Electrical stimulation (0.5 ms pulse duration, 40 V/cm
2,1 –
50 Hz for 10 s) was used to trigger incremental SR Ca
2+ release.
Stimulation was produced with a Myopacer (IonOptix, Milton,
MA) through platinum electrodes placed on either side of the fiber
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perfused 4-CmC onto the fiber (see above) to measure its maximal
release of Ca
2+ from the SR. Stimulation elicited SR release was
then normalized to the 4-CmC result.
Statistical analysis
Statistical analyses were performed using OriginPro 8.0 or
SigmaStat 3.5. All data are presented as mean 6 S.EM. unless
otherwise noted. Statistical significance was assessed using either
parametric two sample t-test, ANOVA or with the non-parametric
Mann-Whitney rank-sum test as indicated. Significance was set at
P,0.05.
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